SY1 Symrise AG

EQS-News: Press Release: Dr Jean-Yves Parisot assumes CEO position from Dr Heinz-Jürgen Bertram

EQS-News: Symrise AG / Key word(s): Personnel/Personnel
Press Release: Dr Jean-Yves Parisot assumes CEO position from Dr Heinz-Jürgen Bertram

29.02.2024 / 13:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


Holzminden, February 29, 2024

Dr Jean-Yves Parisot assumes CEO position from Dr Heinz-Jürgen Bertram
- Tenure of Dr Heinz-Jürgen Bertram ends after 15 successful years as CEO
- Dr Jean-Yves Parisot, an internationally experienced executive from within the company, takes over
- Trustful and smooth transition until end of March 2024 ensured

Dr Heinz-Jürgen Bertram is handing over the CEO position at Symrise AG to Dr Jean-Yves Parisot. In its meeting today, the company’s Supervisory Board, appointed Dr Jean-Yves Parisot, currently Member of the Executive Committee and in charge of the segment Taste, Nutrition & Health, as new CEO effective March 31, 2024. The Supervisory Board also renewed the contract of Dr Jean-Yves Parisot for another four years until the end of September 2028. Dr Heinz-Jürgen Bertram is retiring in the best mutual consent and agreement after 21 years of service at Symrise, of which 19 as a Member of the Executive Committee and 15 as CEO.

Michael König, Chairman of the Supervisory Board of Symrise AG: “Heinz-Jürgen Bertram has shaped our company decisively. Thanks to his excellent work, Symrise today is a global industry leader and a well-respected member of the DAX-40 index. He has put the Symrise product portfolio on a broad, resilient footing. In addition to ensuring constant organic growth, he has sustainably strengthened the company through perfectly fitting acquisitions in strategic growth areas and has thus ideally positioned Symrise for the future. We are deeply grateful to Heinz-Jürgen Bertram for his achievements.”

“We are excited that Jean-Yves Parisot, an internationally experienced executive from within the company, will take over as CEO. In close partnership with Heinz-Jürgen Bertram, he has successfully transformed Symrise into a leading player in taste and nutrition. Symrise will be in the best hands with Jean-Yves Parisot, and a trustful and smooth transition at the top of the company is ensured,” said König.

Dr Heinz-Jürgen Bertram, CEO of Symrise AG: „Today Symrise is an industry leader, combining innovation capability, excellent quality, and sustainability. It is our dedicated global team that is making all that possible, day by day. It has been a privilege to lead the global Symrise team through eventful times. Now is the right moment to pass on to Jean-Yves Parisot so that he can shape the next chapter of our success story.”

Dr Jean-Yves Parisot, Member of the Executive Committee at Symrise AG: „Symrise is built on strong foundations. We are benefitting immensely from that in our current, very demanding business environment. Many in our industry envy us for this position of strength. Our entrepreneurial activities will continue to focus on setting the right strategic course at an early stage to ensure profitable growth. I am grateful for the trust that the Supervisory Board is putting in me, and I am looking forward to the collaboration with the entire Executive Committee to ensure Symrise remains in pole positions in the years to come – for our clients, our employees, our shareholders, and all our stakeholders worldwide.”

Dr Jean-Yves Parisot joined Symrise in 2014 and became Member of the Executive Committee in 2016. He oversees the segment Taste, Nutrition & Health and will continue to do so on an interim basis until a successor for this role has been identified. Dr Jean-Yves Parisot has been President of the International Organization of the Flavor Industry (IOFI) since 2023. Prior to his time at Symrise, he had global leadership roles at Pfizer, Rhone Poulenc/Rhodia, Danisco, Air Liquide and the Diana Group prior to its merger with Symrise. He studied veterinary medicine and holds a MBA degree from HEC Paris.


About Symrise:
Symrise is a global supplier of fragrances, flavorings, cosmetic active ingredients and raw materials, as well as functional ingredients. Its clients include manufacturers of perfumes, cosmetics, food and beverages, the pharmaceutical industry and producers of nutritional supplements and pet food. Its sales of approximately € 4.6 billion in the 2022 fiscal year make Symrise a leading global provider. Headquartered in Holzminden, Germany, the Group is represented in more than 100 locations in Europe, Africa, the Middle East, Asia, the United States and Latin America. Symrise works with its clients to develop new ideas and market-ready concepts for products that form an indispensable part of everyday life. Economic success and corporate responsibility are inextricably linked as part of this process.
Symrise – always inspiring more …

 


29.02.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at -news.com


Language: English
Company: Symrise AG
Mühlenfeldstraße 1
37603 Holzminden
Germany
Phone: +49 (0)5531 90 0
E-mail:
Internet:
ISIN: DE000SYM9999, DE000SYM7787, DE000SYM7704
WKN: SYM999
Indices: DAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1847951

 
End of News EQS News Service

1847951  29.02.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1847951&application_name=news&site_id=research_pool
EN
29/02/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Symrise AG

Charlotte Vaisse ... (+5)
  • Charlotte Vaisse
  • Emmanuel Matot
  • Jean-Baptiste Rouphael
  • Konrad Zomer
  • Thomas Zlowodzki

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 04/25/2024

Having flirted with the 495-point mark on Friday, which could have triggered an extension of the correction, the market has rebounded well since then. Our technical analysis highlights a configuration in which we are only at the start of a powerful rally. Target of 622 points for Stoxx 600 index (+11%) by the end of the year confirmed. Prefer banks to insurance companies in the short term. - ...

Charlotte Vaisse ... (+5)
  • Charlotte Vaisse
  • Emmanuel Matot
  • Jean-Baptiste Rouphael
  • Konrad Zomer
  • Thomas Zlowodzki

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 25/04/2024

Après avoir frôlé vendredi la barre des 495 points qui aurait pu déclencher la poursuite de la correction, le marché a ensuite bien rebondi. Notre analyse technique met en lumière une configuration où nous ne serions qu’au début d’un rallye puissant. Objectif 622 points (+11%) d’ici à la fin de l’année confirmé sur le Stoxx 600. Préférer les banques aux assurances à court terme. - ...

Michael B. Schäfer
  • Michael B. Schäfer

Symrise : Q1 sales with better 10.9% organic growth (cons 9.1%) incl. ...

>Group sales of € 1,292m in Q1 2024, in line with consensus - Symrise reported group sales of €1,292m in Q1 2024, in line with the consensus forecast of € 1,282m (ODDO BHF € 1,273m) and up 5% y-o-y with a 5.6% FX headwind weighing. Organic growth of 10.9% y-o-y was ahead of the consensus at 9.1% (ODDO BHF 8.3%) and compares to the Q4 2023 level of 9.5%, but includes a 4pp FX-based pricing (Argentina) component baked into -1% price vs +11.9% volume against a light comp...

 PRESS RELEASE

EQS-News: Symrise startet erfolgreich in das Geschäftsjahr 2024

EQS-News: Symrise AG / Schlagwort(e): Quartals-/Zwischenmitteilung/Umsatzentwicklung Symrise startet erfolgreich in das Geschäftsjahr 2024 (News mit Zusatzmaterial) 25.04.2024 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Umsatzentwicklung Januar - März 2024   Holzminden, 25. April 2024   Symrise startet erfolgreich in das Geschäftsjahr 2024 — Organisches Wachstum von 10,9 % — Umsatzwachstum von 5,0 % in Berichtswährung — Konzernumsatz steigt auf 1,3 Mrd. € im ersten Quartal — Ziele 2024 und Langfristziele bis 202...

 PRESS RELEASE

EQS-News: Symrise sees successful start into the 2024 fiscal year

EQS-News: Symrise AG / Key word(s): Quarterly / Interim Statement/Development of Sales Symrise sees successful start into the 2024 fiscal year (news with additional features) 25.04.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Trading Update, January – March 2024   Holzminden, Germany, April 25, 2024Symrise sees successful start into the 2024 fiscal year — Organic growth of 10.9 % — Sales growth of 5.0 % in reporting currency — Group sales increase to € 1.3 billion in the first quarter — 2024 targets and long-term targets thro...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch